Uterine Cancer
Uterine Cancer refers to cancerous growths in a woman's uterus. These tumors can be carcinomas or sarcomas.
Cells that line most organs are called epithelial cells, and cancers that develop from these cells are called carcinomas. Cancers that start from "connective tissues," such as muscle, fat, bone, and fibrous tissue (the material that forms tendons and ligaments) are called sarcomas.
Over 95% of cancers of the uterus are carcinomas. Carcinomas develop from epithelial cells, which are cells of the lining layers of the organ. Carcinomas of the lower part of the uterus above the vagina, called the cervix, are called cervical carcinomas. Carcinomas that develop from the lining cells of the upper part of the uterus, called the body or corpus of the uterus, are called endometrial carcinomas.
Around 4% of uterine cancers are sarcomas, which develop from connective tissues, such as muscle, fat, bone, and fibrous tissue (the material that forms tendons and ligaments).
There are three categories of sarcomas, based on the type of cell they developed from:
- Endometrial stromal sarcomas, which develop in the stroma (supporting connective tissue) of the endometrium.
- Uterine leiomyosarcomas, which start in the muscular wall of the uterus.
- Uterine carcinosarcomas, also known as malignant mixed mesodermal tumors or malignant mixed Mullerian tumors (abbreviated as MMMT), which start in the endometrium and have features of both sarcomas and carcinomas.
An estimated 38,300 new cases of cancer of the uterine corpus (body of the uterus), usually of the endometrium, were diagnosed in the United States during 2001. It was estimated that about 6,600 women in the United States died from cancer of the uterine corpus during 2001.
However, even if standard treatments have reached their limits, patients suffering from uterine cancer have treatment options.*
At the Issels Medical Center we have integrated advanced, research-based alternative/complementary and conventional therapies into a comprehensive immunobiological treatment concept that has a 50 year history.
Treatment
The Treatment Program is a comprehensive strategy for uterine cancer of all types and stages.*
It is a two-pronged attack and consists of:
- Non-toxic Immunobiological Treatments designed to attack the cancer and at the same time restore the natural mechanisms of regulation, repair and defense.
- Standard Treatments aimed at the removal or reduction of the cancerous cells and tumors, when indicated and possible.
Each treatment program is specifically designed to meet the individual patient's needs and consists of components that complement one another.
>>> For ADDITIONAL INFORMATION on Treatment and Costs please click here or call 1.888.374.7735
Rationale
In uterine cancer patients, as in all cancer patients, the body's regulatory, repair and immune mechanisms fail to prevent formation of a cancerous tumor. This failure is called by some researchers a "regulatory freeze" or "tolerance," which is due to a combination of causal factors that vary from one individual patient to the other.
The comprehensive immunobiological treatment offered at the Issels Medical Center aims to break through the "regulatory freeze". It is a unique blend of treatment modalities that complement and enhance one another in an effort to attack the cancer and at the same time restore the body's regulatory, repair and immune systems.
Evidence is growing that in addition to genetic disposition, western lifestyle, nutritional imbalances, hormonal and psychological factors, environmental challenges along with other immune suppressive factors play an important part in the development of uterine cancer.
The criteria of diagnosing and staging are the same for every patient suffering from a specific type of cancer. However, even if the histological diagnosis shows the same type of cancerous cell and the staging shows the same state of progression, every patient has his/her own individual cancer as a result from many different combinations of causal factors ranging from inherited constitution and disposition to adapted lifestyle.
Findings of modern research indicate that it is not only the type of cancerous cells that determines the course of the disease, but also the extra-cellular matrix, the medium on which these cells grow, i.e. the internal bodily environment, and the power of the natural defenses against cancer.
Cancer cells develop in every human being, in fact in every vertebrate organism, according to L. Thomas and other researchers. However, not every newly produced cancer cell leads to a tumor, as the body possesses a natural defense system, an immune surveillance according to M. Burnet. An intact immune system and intact regulation of physiological cell death, called apoptosis, protect the organism from the development of a cancerous tumor. Therefore, it is of great importance to restore the natural regulatory, repair and immune mechanisms, as a part of the healing strategy, or as prevention from the outbreak or progression of the disease.
Statistical studies show that the incidence of recurrent cancer can be reduced considerably, if the patient takes action to strengthen the immune system instead of wasting precious time by passively waiting for the next test results.
Surgery, chemotherapy and radiation, although having made great strides in their ability to eradicate cancer cells and tumors, are merely aimed at the malignancy and ignore, and sometimes aggravate, the underlying condition, which led to the formation of the tumor in the first place.
Unless the preconditions for the growth of cancerous tumors are corrected, the high risk of disease progression and recurrence remains.
* DISCLAIMER: The extent of the response to treatment varies from patient to patient, even with similar diagnosis as the internal bodily environment is unique to each individual patient.
>>> For ADDITIONAL INFORMATION on Treatment and Costs please click here or call 1.888.374.7735